155 related articles for article (PubMed ID: 3838920)
1. Effects of atropine and pirenzepine on healing of gastric ulcer induced by mucosal excision in rats.
Sano M; Kitagawa H; Fujiwara M
Clin Ther; 1985; 7(3):380-9. PubMed ID: 3838920
[TBL] [Abstract][Full Text] [Related]
2. Effects of cimetidine and pirenzepine on peroperative electrical vagal stimulation of gastric acid secretion.
Fritsch WP; Schacht U; Scholten T; Hengels KJ; Mueller J; Strasser K
Scand J Gastroenterol Suppl; 1980; 66():95-100. PubMed ID: 6941381
[TBL] [Abstract][Full Text] [Related]
3. Gastric cytoprotection by pirenzepine is not mediated by catecholamines.
Martinotti E; Bernardini C; Del Tacca M; Pellegrini M; Soldani G; Bertelli A
Acta Physiol Hung; 1984; 64(3-4):219-24. PubMed ID: 6549422
[TBL] [Abstract][Full Text] [Related]
4. The inhibition of vagal stimulated acid secretion by pirenzepine and cimetidine.
Scholten T; Fritsch WP; Müller JE; Hengels KJ
Scand J Gastroenterol Suppl; 1982; 72():169-71. PubMed ID: 6957986
[TBL] [Abstract][Full Text] [Related]
5. Effects of pirenzepine and atropine on vagal and cholinergic gastric secretion and gastrin release and on heart rate in the dog.
Hirschowitz BI; Fong J; Molina E
J Pharmacol Exp Ther; 1983 May; 225(2):263-8. PubMed ID: 6132990
[TBL] [Abstract][Full Text] [Related]
6. Gastric cytoprotection by pirenzepine. Role of endogenous prostaglandins.
Konturek SJ; Brzozowski T; Radecki T; Piastucki I
Scand J Gastroenterol Suppl; 1982; 72():255-9. PubMed ID: 6957993
[TBL] [Abstract][Full Text] [Related]
7. Positive modulation of pepsinogen secretion by gastric acidity after vagal cholinergic stimulation.
Blandizzi C; Colucci R; Carignani D; Lazzeri G; Del Tacca M
J Pharmacol Exp Ther; 1997 Dec; 283(3):1043-50. PubMed ID: 9399975
[TBL] [Abstract][Full Text] [Related]
8. Effects of antimuscarinic agents and prostaglandin E2 on the gastric mucosal lesions induced by necrotizing agents and water-immersion stress in rats.
Kitagawa H; Hayashi T; Takeda F; Kinekawa F; Kohei H
Jpn J Pharmacol; 1986 Jul; 41(3):409-14. PubMed ID: 3463816
[TBL] [Abstract][Full Text] [Related]
9. Gastric cytoprotection by pirenzepine: role of endogenous catecholamines.
Bernardini C; Martinotti E; Del Tacca M; Soldani G; Bertelli A
Int J Tissue React; 1984; 6(2):175-80. PubMed ID: 6547413
[TBL] [Abstract][Full Text] [Related]
10. Effects of pirenzepine and atropine on gastric secretory and plasma hormonal responses to sham-feeding in patients with duodenal ulcer.
Konturek SJ; Obtulowicz W; Kwiecień N; Dobrzańska M; Swierczek J; Kopp B; Olesky J
Scand J Gastroenterol Suppl; 1980; 66():63-9. PubMed ID: 6941379
[TBL] [Abstract][Full Text] [Related]
11. Dissociation between acid secretion and mucosal blood flow after treatment of rats with reserpine.
Kitagawa H; Kurahashi K; Fujiwara M
J Pharmacol Exp Ther; 1986 Mar; 236(3):784-8. PubMed ID: 3081706
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the gastric antisecretory and antiulcer potencies of telenzepine, pirenzepine, ranitidine and cimetidine in the rat.
Riedel R; Bohnenkamp W; Eltze M; Heintze K; Prinz W; Kromer W
Digestion; 1988; 40(1):25-32. PubMed ID: 3234616
[TBL] [Abstract][Full Text] [Related]
13. Pirenzepine inhibits acid and pepsinogen secretion by the isolated perfused mouse stomach.
Müller-Lissner SA; Szelenyi I; Engler H; Blum AL
Scand J Gastroenterol Suppl; 1982; 72():101-3. PubMed ID: 6127794
[TBL] [Abstract][Full Text] [Related]
14. [Do anticholinergic drugs still have significance in the therapy of ulcer?].
Stockbrügger R
Leber Magen Darm; 1986 Nov; 16(6):344-57, 377. PubMed ID: 3807633
[No Abstract] [Full Text] [Related]
15. Comparison of the inhibitory effect of three antimuscarinic drugs: pirenzepine, atropine and propantheline on acid secretion and gastric emptying in the conscious rat.
Rodríguez C; Martí-Bonmati E; Esplugues JV; Brage R; Esplugues J
Methods Find Exp Clin Pharmacol; 1986 Jul; 8(7):403-6. PubMed ID: 3762265
[TBL] [Abstract][Full Text] [Related]
16. Anti-ulcer and secretion-inhibitory properties of the tricyclic derivative doxepin in rats and dogs.
Leitold M; Fleissig W; Merk A
Arzneimittelforschung; 1984; 34(4):468-73. PubMed ID: 6547610
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and selectivity of pirenzepine. Review and commentary.
Texter EC; Reilly PA
Scand J Gastroenterol Suppl; 1982; 72():237-46. PubMed ID: 6753118
[TBL] [Abstract][Full Text] [Related]
18. Molecular pharmacological approach to drug actions on the afferent and efferent fibres of the vagal nerve involved in gastric mucosal protection in rats.
Mózsik G; Dömötör A; Abdel-Salam OM
Inflammopharmacology; 2006 Dec; 14(5-6):243-9. PubMed ID: 17139445
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological analysis of the inhibition by pirenzepine and atropine of vagal-stimulated acid secretion in the isolated stomach of the mouse.
Black JW; Shankley NP
Br J Pharmacol; 1986 May; 88(1):291-7. PubMed ID: 3754779
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of the cytoprotective effects of anticholinergic agents on the gastric mucosal lesions produced by intragastric administration of 0.6 M HCl in rats.
Morón F; Pena C; Cuesta E; Mózsik G; Jávor T
Acta Physiol Hung; 1984; 64(3-4):247-52. PubMed ID: 6532117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]